awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38100203-1587EF09-C55B-48D8-8C34-DCE8912CBFEE
Q38100203-1587EF09-C55B-48D8-8C34-DCE8912CBFEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38100203-1587EF09-C55B-48D8-8C34-DCE8912CBFEE
Cyclin-dependent kinase inhibitors closer to market launch?
P2860
Q38100203-1587EF09-C55B-48D8-8C34-DCE8912CBFEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38100203-1587EF09-C55B-48D8-8C34-DCE8912CBFEE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
56b8679b8faaa38516ce30a48a7d0c3991ad8670
P2860
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors.